insights_auto
Why is ORX down 4,50%?
Dive Deeperchevron_right
ORX:STO
Orexo AB
0,96 SEK
arrow_downward
-4,50%(-0,045) 1D
20 ნოე, 14:35:37 GMT+1 · SEK
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ORX...
Open
1,05 SEK
High
1,05 SEK
Low
0,93 SEK
Mkt. cap
334,13 მლნ.
Avg. vol.
785,30 ათ.
Volume
257,32 ათ.
P/E ratio
0,07
52-wk high
22,55 SEK
52-wk low
0,80 SEK
EPS
13,61 SEK
Shares outstanding
35,13 მლნ.
No. of employees
55
Open
1,05 SEK
High
1,05 SEK
Low
0,93 SEK
Mkt. cap
334,13 მლნ.
Avg. vol.
785,30 ათ.
Volume
257,32 ათ.
P/E ratio
0,07
52-wk high
22,55 SEK
52-wk low
0,80 SEK
EPS
13,61 SEK
Shares outstanding
35,13 მლნ.
No. of employees
55
News stories
From web sources and news partners
marketscreener.com
·
1 საათის წინ
Societe Generale sees S&P 500 ending 2027 at 8,500 on AI, earnings support
Traders Union
·
41 წუთის წინ
Mohamed A. El-Erian: S&P 500 may face longest losing streak since 2020 as 10-year Treasury yield falls
Barron's
·
1 საათის წინ
S&P 500 Futures Decline in Premarket Trading; Lennar, Louisiana-Pacific Lag
Profile
Orexo is a Swedish pharmaceutical company that develops improved pharmaceuticals based on innovative formulation technologies that meet large medical needs. Through presence its in the US market, drugs and digital therapies are commercialized to treat opioid use disorder and adjacent diseases. Products targeting other therapeutic areas are developed and commercialized worldwide with partners. Wikipedia
About Orexo AB
CEOნიკოლაი სორენსენი
Employees55
Founded1995
Headquarters-
SectorHealth Care
IndustryPharmaceutical industry
Websiteorexo.com